101 related articles for article (PubMed ID: 25796169)
1. Global metabolic profile identifies choline kinase alpha as a key regulator of glutathione-dependent antioxidant cell defense in ovarian carcinoma.
Granata A; Nicoletti R; Perego P; Iorio E; Krishnamachary B; Benigni F; Ricci A; Podo F; Bhujwalla ZM; Canevari S; Bagnoli M; Mezzanzanica D
Oncotarget; 2015 May; 6(13):11216-30. PubMed ID: 25796169
[TBL] [Abstract][Full Text] [Related]
2. The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth.
Trousil S; Kaliszczak M; Schug Z; Nguyen QD; Tomasi G; Favicchio R; Brickute D; Fortt R; Twyman FJ; Carroll L; Kalusa A; Navaratnam N; Adejumo T; Carling D; Gottlieb E; Aboagye EO
Oncotarget; 2016 Jun; 7(24):37103-37120. PubMed ID: 27206796
[TBL] [Abstract][Full Text] [Related]
3. Alterations of choline phospholipid metabolism in endometrial cancer are caused by choline kinase alpha overexpression and a hyperactivated deacylation pathway.
Trousil S; Lee P; Pinato DJ; Ellis JK; Dina R; Aboagye EO; Keun HC; Sharma R
Cancer Res; 2014 Dec; 74(23):6867-77. PubMed ID: 25267063
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics profiling and chemoresistance mechanisms in ovarian cancer cell lines: Implications for targeting glutathione pathway.
Alarcon-Zapata P; Perez AJ; Toledo-Oñate K; Contreras H; Ormazabal V; Nova-Lamperti E; Aguayo CA; Salomon C; Zuniga FA
Life Sci; 2023 Nov; 333():122166. PubMed ID: 37827232
[TBL] [Abstract][Full Text] [Related]
5. Choline kinase alpha-Putting the ChoK-hold on tumor metabolism.
Arlauckas SP; Popov AV; Delikatny EJ
Prog Lipid Res; 2016 Jul; 63():28-40. PubMed ID: 27073147
[TBL] [Abstract][Full Text] [Related]
6. A non-catalytic role of choline kinase alpha is important in promoting cancer cell survival.
Falcon SC; Hudson CS; Huang Y; Mortimore M; Golec JM; Charlton PA; Weber P; Sundaram H
Oncogenesis; 2013; 2(3):e38. PubMed ID: 25522435
[TBL] [Abstract][Full Text] [Related]
7. A biochemical comparison of the lung, colonic, brain, renal, and ovarian cancer cell lines using 1H-NMR spectroscopy.
Hu C; Liu Z; Zhao H; Wu L; Lian Q; Ma D; Li JV
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32266944
[TBL] [Abstract][Full Text] [Related]
8. Choline kinase alpha genotype is related to hippocampal brain volume and cognition in postmenopausal women.
Myers AJ; Potts C; Makarewicz JA; McGee E; Dumas JA
Heliyon; 2024 Jan; 10(1):e23963. PubMed ID: 38226229
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of tumor initiation and expression of KCNMA1, MORF4L2 and ASPM genes in the adenocarcinoma of lung xenograft after vorinostat treatment.
Kuo WY; Wu CY; Hwu L; Lee JS; Tsai CH; Lin KP; Wang HE; Chou TY; Tsai CM; Gelovani J; Liu RS
Oncotarget; 2015 Apr; 6(11):8663-75. PubMed ID: 25796627
[TBL] [Abstract][Full Text] [Related]
10. PPARα inhibition modulates multiple reprogrammed metabolic pathways in kidney cancer and attenuates tumor growth.
Abu Aboud O; Donohoe D; Bultman S; Fitch M; Riiff T; Hellerstein M; Weiss RH
Am J Physiol Cell Physiol; 2015 Jun; 308(11):C890-8. PubMed ID: 25810260
[TBL] [Abstract][Full Text] [Related]
11. Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target.
Asim M; Massie CE; Orafidiya F; Pértega-Gomes N; Warren AY; Esmaeili M; Selth LA; Zecchini HI; Luko K; Qureshi A; Baridi A; Menon S; Madhu B; Escriu C; Lyons S; Vowler SL; Zecchini VR; Shaw G; Hessenkemper W; Russell R; Mohammed H; Stefanos N; Lynch AG; Grigorenko E; D'Santos C; Taylor C; Lamb A; Sriranjan R; Yang J; Stark R; Dehm SM; Rennie PS; Carroll JS; Griffiths JR; Tavaré S; Mills IG; McEwan IJ; Baniahmad A; Tilley WD; Neal DE
J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26657335
[TBL] [Abstract][Full Text] [Related]
12. A metabolomic approach to identifying platinum resistance in ovarian cancer.
Poisson LM; Munkarah A; Madi H; Datta I; Hensley-Alford S; Tebbe C; Buekers T; Giri S; Rattan R
J Ovarian Res; 2015 Mar; 8():13. PubMed ID: 25880539
[TBL] [Abstract][Full Text] [Related]
13. Characterizing metabolic changes in human colorectal cancer.
Williams MD; Zhang X; Park JJ; Siems WF; Gang DR; Resar LM; Reeves R; Hill HH
Anal Bioanal Chem; 2015 Jun; 407(16):4581-95. PubMed ID: 25943258
[TBL] [Abstract][Full Text] [Related]
14. Choline kinase-α protein and phosphatidylcholine but not phosphocholine are required for breast cancer cell survival.
Mori N; Wildes F; Kakkad S; Jacob D; Solaiyappan M; Glunde K; Bhujwalla ZM
NMR Biomed; 2015 Dec; 28(12):1697-706. PubMed ID: 26503172
[TBL] [Abstract][Full Text] [Related]
15. Exploiting altered patterns of choline kinase-alpha expression on human prostate tissue to prognosticate prostate cancer.
Challapalli A; Trousil S; Hazell S; Kozlowski K; Gudi M; Aboagye EO; Mangar S
J Clin Pathol; 2015 Sep; 68(9):703-9. PubMed ID: 26041862
[TBL] [Abstract][Full Text] [Related]
16. Unearthing FLVCR1a: tracing the path to a vital cellular transporter.
Fiorito V; Tolosano E
Cell Mol Life Sci; 2024 Apr; 81(1):166. PubMed ID: 38581583
[TBL] [Abstract][Full Text] [Related]
17. MALAT1 as a Regulator of the Androgen-Dependent Choline Kinase A Gene in the Metabolic Rewiring of Prostate Cancer.
De Martino S; Iorio E; Cencioni C; Aiello A; Spallotta F; Chirico M; Pisanu ME; Grassi C; Pontecorvi A; Gaetano C; Nanni S; Farsetti A
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740569
[TBL] [Abstract][Full Text] [Related]
18. ATP8B1 Knockdown Activated the Choline Metabolism Pathway and Induced High-Level Intracellular REDOX Homeostasis in Lung Squamous Cell Carcinoma.
Zhang X; Zhang R; Liu P; Zhang R; Ning J; Ye Y; Yu W; Yu J
Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159102
[TBL] [Abstract][Full Text] [Related]
19. Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases.
Lacal JC; Zimmerman T; Campos JM
Pharmaceutics; 2021 May; 13(6):. PubMed ID: 34070409
[TBL] [Abstract][Full Text] [Related]
20. Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells.
Rizzo A; Satta A; Garrone G; Cavalleri A; Napoli A; Raspagliesi F; Figini M; De Cecco L; Iorio E; Tomassetti A; Mezzanzanica D; Bagnoli M
J Exp Clin Cancer Res; 2021 Jan; 40(1):5. PubMed ID: 33390181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
